Graybug Vision (NASDAQ:GRAY) Trading Down 8.6% – What’s Next?

Graybug Vision, Inc. (NASDAQ:GRAY) dropped 8.6% on Tuesday . The stock traded as low as $0.52 and last traded at $0.52. Approximately 94,824 shares were traded during mid-day trading, an increase of 4,280% from the average daily volume of 2,165 shares. The stock had previously closed at $0.5690.

Graybug Vision Price Performance

The company has a market capitalization of $848,340.00, a PE ratio of -0.31 and a beta of 1.20. The stock’s 50 day simple moving average is $1.15 and its 200-day simple moving average is $3.05.

Graybug Vision Company Profile

Graybug Vision, Inc is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for retinal diseases. The company’s proprietary Depot Technology Platform is designed to deliver sustained-release formulations of biologically active agents directly to the back of the eye, with the goal of reducing treatment burden and improving patient outcomes. Graybug’s lead product candidate, GB-102, is a long-acting formulation of sunitinib malate being investigated for the treatment of wet age-related macular degeneration (wet AMD).